NDC codes

415464 NDC codes with hospital pricing data in the network.

• NDC 61570-0131-50 — Silvadene 1% topical creamAI (449 hospitals, 30,432–31,431 samples)
• NDC 51672-4081-03 — Clindamycin topical solution 1%AI (84 hospitals, 30,473–31,427 samples)
• NDC 65862-0946-01 — Dorzolamide-timolol eye dropsAI (371 hospitals, 30,473–31,427 samples)
• NDC 70512-0520-05 — Olopatadine eye drops 0.1%AI (239 hospitals, 30,473–31,427 samples)
• NDC 70710-1197-01 — Rivastigmine 9.5 mg per 24-hour skin patchAI (52 hospitals, 30,473–31,427 samples)
• NDC 70710-1302-06 — Mesalamine 1000 mg rectal suppositoryAI (125 hospitals, 30,473–31,427 samples)
• NDC 00168-0006-80 — TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL OINTMENTAI (263 hospitals, 30,434–31,424 samples)
• NDC 61314-0637-10 — Prednisolone acetate 1% eye dropsAI (323 hospitals, 30,377–31,421 samples)
• NDC 76204-0900-11 — Levalbuterol 1.25 mg nebulizer solutionAI (482 hospitals, 30,440–31,412 samples)
• NDC 61314-0646-10 — Neomycin-polymyxin-hydrocortisone ear dropsAI (363 hospitals, 30,492–31,410 samples)
• NDC 00536-1294-97 — Diclofenac sodium 1% topical gelAI (344 hospitals, 30,455–31,409 samples)
• NDC 00487-9007-30 — Hypertonic saline nebulizer solutionAI (270 hospitals, 30,453–31,398 samples)
• NDC 50268-0568-15 — Mupirocin 2% topical ointmentAI (253 hospitals, 30,398–31,397 samples)
• NDC 45802-0138-35 — Ciclopirox 0.77% cream, 15 g tubeAI (249 hospitals, 30,398–31,397 samples)
• NDC 00487-0201-60 — Ipratropium-albuterol nebulizer solutionAI (199 hospitals, 30,383–31,382 samples)
• NDC 50474-0970-75 — Brivaracetam 50 mg/5 mL intravenous solutionAI (415 hospitals, 30,030–31,380 samples)
• NDC 00121-0893-40 — CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASHAI (171 hospitals, 30,344–31,379 samples)
• NDC 50383-0775-15 — Lidocaine 2% mucosal solutionAI (293 hospitals, 30,468–31,377 samples)
• NDC 66794-0229-02 — ROCURONIUM 10 MG/ML INTRAVENOUS SOLUTIONAI (123 hospitals, 30,349–31,375 samples)
• NDC 66794-0229-41 — ROCURONIUM 10 MG/ML INTRAVENOUS SOLUTIONAI (145 hospitals, 30,349–31,375 samples)
• NDC 65862-0840-03 — Moxifloxacin 0.5% eye drops, 3 mL bottleAI (405 hospitals, 30,426–31,371 samples)
• NDC 63323-0494-41 — Valproate sodium 500 mg/5 mL intravenous solutionAI (152 hospitals, 30,361–31,369 samples)
• NDC 45802-0109-01 — Triamcinolone nasal sprayAI (124 hospitals, 30,331–31,366 samples)
• NDC 36000-0149-10 — Flumazenil injection (benzodiazepine reversal medicine)AI (133 hospitals, 30,312–31,365 samples)
• NDC 47335-0756-52 — Ipratropium-albuterol nebulizer solutionAI (163 hospitals, 30,312–31,365 samples)
• NDC 50190-0142-63 — Hypertonic saline 3% nebulizer solutionAI (516 hospitals, 30,375–31,356 samples)
• NDC 59762-5007-01 — Misoprostol 100 mcg tabletsAI (658 hospitals, 30,707–31,355 samples)
• NDC 61570-0131-85 — SILVER SULFADIAZINE 1 % TOPICAL CREAMAI (81 hospitals, 30,322–31,348 samples)
• NDC 00168-0003-80 — TRIAMCINOLONE ACETONIDE 0.025 % TOPICAL CREAMAI (161 hospitals, 30,393–31,347 samples)
• NDC 00713-0132-06 — PROMETHAZINE 50 MG RECTAL SUPPOSITORYAI (103 hospitals, 30,393–31,347 samples)
• NDC 00168-0006-16 — Triamcinolone 0.1% topical ointmentAI (195 hospitals, 30,343–31,342 samples)
• NDC 70954-0518-10 — Lidocaine 4% topical solutionAI (475 hospitals, 30,214–31,339 samples)
• NDC 00517-0375-10 — Indigo carmine dye injection solutionAI (229 hospitals, 31,074–31,335 samples)
• NDC 63323-0417-10 — Cisatracurium besylate injection, 20 mg/10 mL IVAI (499 hospitals, 30,163–31,333 samples)
• NDC 50190-0141-23 — Sodium chloride 7% nebulizer solutionAI (275 hospitals, 30,424–31,333 samples)
• NDC 42291-0077-15 — Clobetasol propionate 0.05% topical ointmentAI (251 hospitals, 30,463–31,327 samples)
• NDC 65219-0535-50 — Intravenous fat emulsion, 20% solutionAI (226 hospitals, 30,463–31,327 samples)
• NDC 00990-6143-09 — ACETIC ACID 0.25 % IRRIGATION SOLUTIONAI (131 hospitals, 30,353–31,325 samples)
• NDC 17478-0892-25 — DICLOFENAC 0.1 % EYE DROPSAI (107 hospitals, 30,424–31,324 samples)
• NDC 00574-4021-35 — Bacitracin and polymyxin B eye ointmentAI (264 hospitals, 30,409–31,318 samples)
• NDC 61314-0238-05 — Carteolol 1% eye drops, 5 mL bottleAI (300 hospitals, 30,307–31,315 samples)
• NDC 17478-0605-10 — Dorzolamide-timolol eye dropsAI (143 hospitals, 30,541–31,315 samples)
• NDC 00121-1154-30 — Lactulose oral solution 10 g per 15 mLAI (433 hospitals, 30,276–31,311 samples)
• NDC 00409-0155-01 — Dexmedetomidine IV infusion in salineAI (49 hospitals, 30,337–31,309 samples)
• NDC 60687-0244-77 — Fluoxetine 20 mg/5 mL oral liquidAI (95 hospitals, 30,306–31,305 samples)
• NDC 69367-0243-12 — Hydrocortisone 25 mg rectal suppositoryAI (179 hospitals, 30,306–31,305 samples)
• NDC 45802-0054-36 — TRIAMCINOLONE ACETONIDE 0.025 % TOPICAL OINTMENTAI (89 hospitals, 30,351–31,305 samples)
• NDC 45802-0064-36 — Triamcinolone 0.1% topical creamAI (368 hospitals, 30,306–31,305 samples)
• NDC 45802-0221-35 — Fluticasone 0.005% ointment, 15 g tubeAI (101 hospitals, 30,306–31,305 samples)
• NDC 00409-7969-05 — Cardioplegic solution, preservative-freeAI (188 hospitals, 30,351–31,305 samples)